Search

You searched for "sustainability"

127 results found

History of prostate biopsy – part 2

1 September 2018 | | URO - Basic Science Research, URO - Urologic Oncology, URO - Technology
For Part 1 of this topic is available here. The major limitations of the transrectal ultrasound (TRUS) guided prostate biopsy (PBx) protocols are the risk of profound sepsis and the risk of persistently significant false negative rates, related to the...

Priapism

7 January 2021 | | URO - Andrology
Priapism is defined as an abnormally persistent erection lasting greater than four hours, not associated with sexual desire [1]. Although relatively uncommon with an incidence of 1.5 per 100,000 [2], priapism has a risk of complications which can have a...

In conversation with Jane Brocksom

9 March 2020 | URO - Core Urology
We were delighted to chat to Jane Brocksom, President of BAUN, about her background in urology nursing and plans for the association in its 25th year. Can you tell us a bit about your background and what led you into...

In conversation with Matthew Bultitude

27 November 2025 | URO - Core Urology
Matthew Bultitude. Can you tell us a little bit about what led you into the field of urology and what have been the highlights so far? Thank you and that is a very interesting question given that my father was...
European Urology journal front cover image with Editor's Choice stamp.

Prostate cancer mortality among elderly men after discontinuing organised screening

4 March 2024 | | URO - Urologic Oncology
This study presents ground-breaking insights into discontinuing prostate cancer (PCa) screening in previously screened elderly men, aiming to mitigate the risk of overdiagnosis and overtreatment in the face of other-cause mortality. Examining men aged 70–74 who had undergone prostate specific...

Initial impressions of urology in the UK from overseas trainees

3 September 2021 | | URO - Core Urology
Readers of Urology News will be familiar with descriptions of overseas visits by UK-based urological trainees, but it is sometimes beneficial to reflect on the experience of international medical graduates (IMGs) who elect to come to work and train in...

MRI screening for prostate cancer: a step towards a ‘prostagram’

7 January 2020 | | URO - Urologic Oncology, URO - Technology
The UK National Screening Committee has been calling for further research into alternative screening tests for prostate cancer. The committee decided against prostate cancer screening using prostate specific antigen (PSA) testing on the basis that “PSA is still a poor...

Using cryopreserved prepubertal testis tissues – are we getting warmer?

12 September 2023 | | URO - Andrology, URO - Basic Science Research, URO - Urologic Oncology
The rising incidence of childhood cancer coupled with increasing survivorship means there is a growing population of childhood cancer survivors with unmet health needs. In the UK around 1 in 500 children and young people are survivors of childhood cancer....

Surgical risk prediction

1 November 2017 | | URO - Technology
Patients presenting for urological surgery range from the young and fit to the elderly with multiple, and often significant, coexistent diseases. This latter cohort can present a significant challenge in the perioperative period, sometimes irrespective of the type of surgery....

Bladder Health UK

2 November 2023 | | URO - Functional / Reconstructive Urology, URO - Infection
- CHARITY FOCUS - Bladder Health UK is a national patient support charity that has been communicating with bladder illness sufferers for 30 years. The charity offers a lot of resources to give help, educate and inform, including webinars, study...

Cutting-edge or over-hyped? Evaluating the role of robotic surgery in the management of renal cell carcinoma

3 May 2024 | | URO - Urologic Oncology
The quest for a minimally-invasive approach to major abdominal surgery finds its roots at the start of the previous century, when Georg Kelling first described the technique of ‘ceolioscopy’ to inspect intraabdominal organs in 1901 [1]. Since those early days,...

IBSA UK&I launches Perovial®: the first licensed injectable option for men with acute Peyronie’s disease

2 February 2026 | Company Profiles, Recruitment & Personnel
A clinically supported option for early intervention in a historically underdiagnosed and undertreated condition. IBSA UK&I today (Monday 2 February 2026) announces the launch of Perovial®, the first licensed hyaluronic acid injectable indicated for the management of Peyronie’s disease (PD)...